一名携带 MET 扩增的胆囊源性神经内分泌癌患者对卡帕替尼的反应

IF 0.5 Q4 ONCOLOGY

International Cancer Conference Journal Pub Date : 2024-01-02 DOI:10.1007/s13691-023-00643-5

Shogo Yamamura, Masashi Kanai, Yasuhide Takeuchi, N. Okita, Tomohiro Kondo, Masahiro Yoshioka, J. Matsubara, S. Matsumoto, Manabu Muto

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Cancer Conference Journal ONCOLOGY-

自引率

14.30%

发文量

期刊介绍： This online-only journal publishes original case reports on all types of cancer. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on molecularly analyzed cancer cases, including gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Assessing the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop precision medicine solutions in the future. We welcome case reports with reviews of the literature on similar cases, as they are more useful and valuable to readers than are reports of rare cases. International Cancer Conference Journal is the official publication of the Japan Society of Clinical Oncology (JSCO). - Presents an online-only collection of original case reports on all types of cancer - In particular, welcomes molecularly analyzed cancer cases - The Official Publication of the Japan Society of Clinical Oncology (JSCO)